Dr. Rowe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2000 6th Ave S
Birmingham, AL 35233Phone+1 205-934-9999Fax+1 205-934-1721- Is this information wrong?
Education & Training
- University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2006
- University of Alabama Medical CenterResidency, Internal Medicine/Pediatrics, 1998 - 2002
- Vanderbilt University School of MedicineClass of 1998
Certifications & Licensure
- AL State Medical License 1999 - 2024
Clinical Trials
- Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators Start of enrollment: 2010 Mar 01
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- TOPIC Trial for COPD Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- Potential systemic effects of acquired CFTR dysfunction in COPD.Miravitlles, M., Mall, M., Vogelmeier, C., Hederer, B., Schoenberger, M., Altman, P., Criner, G., Rowe, S.> ;Respiratory Medicine. 2024 Jan 1
- 17 citationsEngineered tRNAs suppress nonsense mutations in cells and in vivo.Suki Albers, Elizabeth C Allen, Nikhil Bharti, Marcos Davyt, Disha Joshi, Carlos G Perez-Garcia, Leonardo Santos, Rajesh Mukthavaram, Miguel Angel Delgado-Toscano, Bra...> ;Nature. 2023 Jun 1
- 2 citationsPlasma and cellular ivacaftor concentrations in patients with cystic fibrosis.Jennifer S Guimbellot, Kevin J Ryan, Justin D Anderson, Kennedy L Parker, Lauren Victoria Odom, Steven M Rowe, Edward P Acosta> ;Pediatric Pulmonology. 2022 Nov 1
- Join now to see all
Journal Articles
- Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized TrialSteven Rowe, MD, Dove Press
- Ivacaftor Improves Rhinologic, Psychologic, and Sleep‐Related Quality of Life in G551D Cystic Fibrosis PatientsBradford A Woodworth, Justin McCormick, Steven M Rowe, Brooks Lampkin, International Forum of Allergy & Rhinology
- Non-Obstructive Vas Deferens and Epididymis Loss in Cystic Fibrosis RatsJ S Hong, E J Sorscher, S M Rowe, ScienceDirect
- Join now to see all
Press Mentions
- Interdisciplinary Work Highlighted at COVID-19 Research SymposiumOctober 29th, 2020
- Minimally Invasive Imaging Device Shows Changes in Nasal Airways, May Allow Earlier CF DiagnosisAugust 13th, 2019
- New Intra-Nasal Imaging to Study Airways in Patients with Cystic FibrosisAugust 7th, 2019
- Join now to see all
Grant Support
- Clinical And Translational CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2012
- Molecular Pathogenesis And Phenotype Of Acquired CFTR Dysfunction In COPDNational Heart, Lung, And Blood Institute2011–2012
- Mechanistic Basis Underlying Protein Repair Of CFTR Nonsense MutationsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Clinical And Mechanistic Features Of Premature Termination Codon SuppressionNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Premature Termination Codon SuppressionNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Hospital Affiliations
- Children's of AlabamaBirmingham, Alabama
- University of Alabama HospitalBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: